undamentalytics Newsletter
Sign in

Ainos, Inc. (AIMD) stock

Add to watchlist

Add holding +

NASDAQ: AIMD Nasdaq Health Care Equipment Next results ~November 12, 2026

Ainos, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Ainos, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 3 selling9 purchases and 9 sales by directors and officers, last 12 monthsInsider trades
  • Funds6 adding, 4 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Ainos files

Where Ainos stands after its latest 10-Q

Ainos has little or no product revenue yet; it used $4m of cash in the twelve months to June 2026. That puts it 103 of 103 for growth among the health care equipment companies we cover. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 1 of our 3 financial-health checks.

Our model value for Ainos is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 3, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 12, 2026 (estimated)

Ainos, Inc.'s trailing-twelve-month revenue fell 87.7% year on year, with a free-cash-flow margin of -33046.9%.

Current signal Operating margin compressing: TTM operating margin fell to -101210.2%, down 88059.0pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Results due soon. Results are expected around 12 November; the share price can move sharply on the day.
  • Revenue shrinking. Revenue fell 87.7% over the last 12 months.
  • Loss-making. Operating margin is -101210.2%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 88059.0 points on a year ago.
  • Burning cash. Free cash flow was -33046.9% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 1391.8% of revenue: a real cost that cash-flow figures leave out.

Latest results: FY2026 Q2

Filed August 3, 2026
Revenue
$0m, down 96.7% on a year earlier
Share reaction
+6.0% in the first session after the results on August 3, 2026, against +3.3% for the S&P 500

Ainos' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.4%
  • 1 week-20.8%
  • 1 month-54.2%
  • This year-62.2%
  • 1 year-81.2%
  • 5 years-99.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$13,600
Operating margin
-101210.2%
Net margin
-106283.3%
EPS (TTM, diluted)
$-2.49

Growth

Revenue growth
−87.7%
Change in growth rate
−4.8 pts

Cash

Free cash flow (TTM)
-$4.5M
FCF margin
-33046.9%
Stock pay % of revenue
1391.8%

Earnings

Last results
August 3, 2026
Next results (est.)
November 12, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Agreement
  3. Results
  4. Financing

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Ainos, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

Valuation multiples over time Market data may be delayed

At fiscal year end 2021202320242025Now
Share price$315.00$10.25$2.28$1.64$0.62
Market value$2.4bn$42m$4m$7m$4m
+ Net debt (− = net cash)$2m$1m$8m$11m−$1m
Enterprise value$2.4bn$43m$12m$18m$2m
Multiples
Price / sales n/mn/mn/m56.4xn/m
Price / earnings —————
Price / free cash flow —————
EV / EBITDA —————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

20 /100

Weak moat

How hard Ainos's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -62.0% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 45.5%, moving by 112.0 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -6311.6%; its worst year was -104643.0%.

  • Cash conversion 2 / 20

    Free cash flow was positive in 1 of 5 years, at a median -4465.9% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 6785.1% over five years; stock-based pay has been a median 912.9% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Ainos, Inc.: too few analysts cover it.

Management guidance

Earnings release, August 3, 2026

No numeric guidance in Ainos, Inc.'s latest earnings release (filed August 3, 2026). Some companies give their outlook only on the earnings call.

Positioning

Short interest
1.3%
of tradable shares
Days to cover
0.15
at average volume
Short interest, 1 month
−16%
to October 15, 2026
Held by institutions
2%
of shares
Held by insiders
70.9%
of shares
Employees
41
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 20222023202420252026 to date
Return
AIMD−95%−34%−78%−28%−62%
Industry peers (median)−37%−8%−19%−16%−13%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
AIMD33%33%25%33%36%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
AIMD−97%−75%−85%−61%−80%
S&P 500−25%−10%−8%−19%−9%

Worst fall since January 8, 2021: 100% from June 7, 2021 to November 2, 2026. Getting back needed a 126311% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.62 – $3.38
From 52-week high
−81.7%
vs 50-day average
−49.3%
vs 200-day average
−61.0%
Volatility (1 year)
139%
Beta vs S&P 500
2.76

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±11.2%
After a week
6 up, 6 down
typical move ±8.6%
After a month
6 up, 6 down
typical move ±11.0%
Results releasedNext dayS&P 500 next day5 days21 days
August 3, 2026 +6.0% +3.3% +7.5% +4.5%
May 13, 2026 +2.4% +1.4% −10.7% +13.7%
March 30, 2026 0.0% +2.6% +6.5% +23.7%
November 13, 2025 −22.7% −1.7% −33.2% −24.8%
August 13, 2025 +17.5% +0.4% +6.5% +9.5%
May 12, 2025 0.0% +4.0% −2.2% +3.0%
March 7, 2025 −3.2% −2.1% +9.7% +4.8%
August 5, 2024 −22.4% −2.0% −11.9% −4.5%
May 13, 2024 −1.0% +0.5% −4.9% −19.1%
March 8, 2024 +46.4% −0.7% +8.0% −7.1%
November 13, 2023 −4.7% +1.8% −2.3% −15.8%
August 11, 2023 +8.7% +0.5% +0.3% −1.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Ainos, Inc.
$0 $500K $1M $1.5M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $1.1M Revenue (TTM), FY23 Q4: $122.1K Revenue (TTM), FY24 Q1: $93.7K Revenue (TTM), FY24 Q2: $65.1K Revenue (TTM), FY24 Q3: $40.6K Revenue (TTM), FY24 Q4: $20.7K Revenue (TTM), FY25 Q1: $106.2K Revenue (TTM), FY25 Q2: $110.9K Revenue (TTM), FY25 Q3: $113K Revenue (TTM), FY25 Q4: $124.2K Revenue (TTM), FY26 Q1: $18.1K Revenue (TTM), FY26 Q2: $13.6K $13.6K

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $1.1M
FY23 Q4 $122.1K
FY24 Q1 $93.7K
FY24 Q2 $65.1K
FY24 Q3 $40.6K
FY24 Q4 $20.7K
FY25 Q1 $106.2K
FY25 Q2 $110.9K
FY25 Q3 $113K
FY25 Q4 $124.2K
FY26 Q1 $18.1K
FY26 Q2 $13.6K
Revenue growth, TTM YoY Ainos, Inc.
-200% 0% 200% 400% 600% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -54.5% Revenue growth, TTM YoY, FY23 Q4: -96.5% Revenue growth, TTM YoY, FY24 Q1: -97.3% Revenue growth, TTM YoY, FY24 Q2: -97.7% Revenue growth, TTM YoY, FY24 Q3: -96.4% Revenue growth, TTM YoY, FY24 Q4: -83.0% Revenue growth, TTM YoY, FY25 Q1: 13.4% Revenue growth, TTM YoY, FY25 Q2: 70.2% Revenue growth, TTM YoY, FY25 Q3: 178.2% Revenue growth, TTM YoY, FY25 Q4: 499.0% Revenue growth, TTM YoY, FY26 Q1: -82.9% Revenue growth, TTM YoY, FY26 Q2: -87.7% -87.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -54.5%
FY23 Q4 -96.5%
FY24 Q1 -97.3%
FY24 Q2 -97.7%
FY24 Q3 -96.4%
FY24 Q4 -83.0%
FY25 Q1 13.4%
FY25 Q2 70.2%
FY25 Q3 178.2%
FY25 Q4 499.0%
FY26 Q1 -82.9%
FY26 Q2 -87.7%
Operating margin (TTM) Ainos, Inc.
-150000% -100000% -50000% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -844.7% Operating margin (TTM), FY23 Q4: -10815.0% Operating margin (TTM), FY24 Q1: -14745.8% Operating margin (TTM), FY24 Q2: -22336.3% Operating margin (TTM), FY24 Q3: -36691.2% Operating margin (TTM), FY24 Q4: -66772.2% Operating margin (TTM), FY25 Q1: -13072.6% Operating margin (TTM), FY25 Q2: -13151.1% Operating margin (TTM), FY25 Q3: -12674.0% Operating margin (TTM), FY25 Q4: -11268.3% Operating margin (TTM), FY26 Q1: -72393.5% Operating margin (TTM), FY26 Q2: -101210.2% -101210.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -844.7%
FY23 Q4 -10815.0%
FY24 Q1 -14745.8%
FY24 Q2 -22336.3%
FY24 Q3 -36691.2%
FY24 Q4 -66772.2%
FY25 Q1 -13072.6%
FY25 Q2 -13151.1%
FY25 Q3 -12674.0%
FY25 Q4 -11268.3%
FY26 Q1 -72393.5%
FY26 Q2 -101210.2%
FCF margin (TTM) Ainos, Inc.
-40000% -30000% -20000% -10000% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -352.0% FCF margin (TTM), FY23 Q4: -3920.7% FCF margin (TTM), FY24 Q1: -5105.2% FCF margin (TTM), FY24 Q2: -8625.5% FCF margin (TTM), FY24 Q3: -15560.0% FCF margin (TTM), FY24 Q4: -28122.9% FCF margin (TTM), FY25 Q1: -5262.0% FCF margin (TTM), FY25 Q2: -4465.9% FCF margin (TTM), FY25 Q3: -4123.3% FCF margin (TTM), FY25 Q4: -3744.7% FCF margin (TTM), FY26 Q1: -24200.8% FCF margin (TTM), FY26 Q2: -33046.9% -33046.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -352.0%
FY23 Q4 -3920.7%
FY24 Q1 -5105.2%
FY24 Q2 -8625.5%
FY24 Q3 -15560.0%
FY24 Q4 -28122.9%
FY25 Q1 -5262.0%
FY25 Q2 -4465.9%
FY25 Q3 -4123.3%
FY25 Q4 -3744.7%
FY26 Q1 -24200.8%
FY26 Q2 -33046.9%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 0 0 0 0 0 0 0 0 0 0 1 4 0 0 0 0
Gross profit 0 0 0 — — — 0 0 0 0 0 1 −0 −0 0 0
EBITDA −1 −1 −1 −1 — −1 −1 −1 −2 −1 −2 −9 −8 −9 −9 −9
Operating income −1 −1 −1 −1 — −1 −1 −1 −2 −1 −4 −14 −13 −14 −14 −14
Net income 1 −1 −1 −1 — −1 −1 −1 −2 −1 −4 −14 −14 −15 −15 −14
Diluted EPS $0.15 −$0.30 −$0.15 −$0.15 — −$0.45 −$0.45 −$0.60 −$0.60 −$0.60 −$0.45 — −$3.36 −$7.82 −$3.46 −$2.49
Growth (year on year)
Revenue — +>999% −99.1% −100.0% — — — −69.0% −84.9% +41.2% +>999% +492.0% −96.5% −83.0% +499.0% −87.7%
Net income — −359.5% — — — — — — — — — — — — — —
Diluted EPS — −300.0% — — — — — — — — — — — — — —
Margins
Gross margin 42.9% 92.5% 60.0% — — — 76.0% 16.5% 25.2% 31.9% 69.0% 39.9% −207.8% −153.7% 82.9% 78.7%
EBITDA margin <−999% <−999% <−999% — — — −215.1% <−999% <−999% <−999% −306.6% −259.8% <−999% <−999% <−999% <−999%
Operating margin <−999% <−999% <−999% — — — −231.0% <−999% <−999% <−999% −650.5% −397.1% <−999% <−999% <−999% <−999%
Net margin >999% <−999% <−999% — — — −246.0% <−999% <−999% <−999% −654.0% −398.0% <−999% <−999% <−999% <−999%
Free-cash-flow margin — — — — — — — <−999% <−999% <−999% −234.4% −104.4% <−999% <−999% <−999% <−999%
Cash flow
Cash from operations −1 −0 −0 −1 — −0 −0 −1 −1 −0 −1 −3 −5 −6 −5 −4
Capital spending — — — — — 0 — 0 0 0 0 1 0 0 0 0
Free cash flow — — — — — −0 — −1 −1 −0 −1 −4 −5 −6 −5 −4
Stock-based pay 0 0 0 — — — 0 0 0 0 −0 6 1 4 2 —
Free cash flow after stock pay — — — — — — — −1 −1 −1 −1 −10 −6 −9 −6 —
Balance sheet
Cash 0 0 0 0 0 0 2 1 0 0 2 2 2 4 0 1
Total debt 0 0 0 0 0 0 0 0 0 1 4 0 3 12 11 —
Net debt (negative = net cash) −0 0 −0 −0 −0 −0 −2 −1 0 1 2 −1 1 8 11 −1
Diluted shares 4m 4m 5m 5m — 1m 2m 2m 3m 3m 8m — 4m 2m 4m 6m
Returned to shareholders
Buybacks — — — 0 — — — — — — — — — — — —
Total returned — — — 0 — — — — — — — — — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 3 checks passed · June 30, 2026
What it owns · $20m
Short-term assets $2mLonger-term assets $17m
What it owes, and who funded it · $20m
Short-term liabilities $16mLonger-term liabilities $0mShareholders' equity $3m
  • Short-term assets cover short-term liabilities $2m of assets due within a year against $16m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $2m short-term assets against $0 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$14m against $730,539 of interest.

From Ainos, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

R&D spending
56280.6%
of revenue
Sales & admin spending
45008.3%
of revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated AIMD CUPR HSCS POAS PAVM NXL Median
Revenue, last 12 months $13600 $38204 $4519 $102806 $112000 $217155 $95m
Revenue growth, last 12 months −87.7% 5.6% −64.2% −18.2% −89.0% 24.2% 9.1%
Revenue growth, 3-year average −83.2% — — — −49.6% −30.6% 13.0%
Revenue growth, latest quarter −96.7% — 10.5% — 450.0% −82.8% 9.9%
Gross margin 78.7% −1.3% 60.9% 13.1% −220.5% 86.2% 61.3%
Operating margin <−999% <−999% <−999% <−999% <−999% <−999% −8.7%
Operating margin, 3-year average <−999% — <−999% — <−999% <−999% −17.9%
Net margin <−999% <−999% <−999% <−999% <−999% <−999% −12.1%
Cash from operations / revenue <−999% <−999% <−999% <−999% <−999% <−999% −2.1%
Free-cash-flow margin <−999% <−999% <−999% <−999% <−999% <−999% −4.0%
Free-cash-flow margin, 3-year average <−999% — — — <−999% <−999% −7.7%
Stock pay / revenue >999% — >999% — >999% >999% 6.3%
Change in share count 178.1% 13.7% 200.7% 19.7% 14.0% 52.1% 4.0%

Median of all 135 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Who owns it

Funds buying and selling
Reported value
$335,978
Institutions reporting
14
Shares held vs prior quarter
▲ 30.4%
Positions opened / closed
3 / 0

Top buyers and sellers, Q2 2026: 6 institutions bought and 4 sold ; the biggest buyer was HRT Financial LP (+32K shares) and the biggest seller Mariner, LLC (−15K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Geode Capital Management, LLC $85,526 44K 25.5% ▼ 16.9%
HRT Financial LP $62,000 32K 18.5% New
Keystone Financial Group $49,568 26K 14.8% ▲ 75.6%
Vanguard Capital Management LLC $31,087 16K 9.3% ▲ 72.7%
Mariner, LLC $30,652 16K 9.1% ▼ 48.7%
Vanguard Fiduciary Trust Co $27,488 14K 8.2% 0.0%
Jane Street Group, LLC $22,318 12K 6.6% New
UBS Group AG $8,909 5K 2.7% ▲ 229500.0%
Tower Research Capital LLC (TRC) $6,125 3K 1.8% ▼ 28.9%
Blackrock, Inc. $5,946 3K 1.8% 0.0%
Seneschal Advisors, LLC $3,492 2K 1.0% 0.0%
Steward Partners Investment Advisory, LLC $2,344 1K 0.7% 0.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ainos, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $21,261 9 trades by 1 insider, last 12 months Insider sales History → $490,043 9 trades by 3 insiders · 0% under pre-set plans
Net ▼ $468,782 net selling
Insider Date Trade Shares Price Value
Chiang Yao-Chung Director June 5, 2026 Buy 3,500 $2.05 $7,175
Chiang Yao-Chung Director June 3, 2026 Buy 2,000 $2.13 $4,260
Chiang Yao-Chung Director May 28, 2026 Buy 250 $2.30 $575
Chiang Yao-Chung Director May 27, 2026 Buy 2,000 $2.00 $4,000
Tsai Chun-Jung Director May 26, 2026 Sell 27,718 $1.87 $51,833
Taiwan Carbon Nano Technology Corp 10% owner May 26, 2026 Sell 41,000 $2.36 $96,760
Lee Ting-Chuan Director May 26, 2026 Sell 109,988 $1.90 $208,977
Lee Ting-Chuan Director May 22, 2026 Sell 9,302 $1.57 $14,604
Tsai Chun-Jung Director May 22, 2026 Sell 1,082 $1.55 $1,677
Lee Ting-Chuan Director May 21, 2026 Sell 9,000 $1.56 $14,040
Chiang Yao-Chung Director May 19, 2026 Buy 2,200 $1.68 $3,696
Chiang Yao-Chung Director May 18, 2026 Buy 500 $1.65 $825

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 12, 2026 estimated from the company's past filing pattern, not announced

  • August 3, 2026
  • May 13, 2026
  • March 30, 2026
  • November 13, 2025
  • August 13, 2025
  • May 12, 2025

Recent SEC filings

Data status

When each part of this page on Ainos, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Ainos, Inc. in brief

What does Ainos, Inc. do?
Ainos, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Ainos, Inc.'s stock ticker?
Ainos, Inc. trades under the ticker AIMD on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Ainos, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Ainos, Inc. reported revenue of $13,600, 87.7% lower than a year earlier, according to its SEC filings.
What is Ainos, Inc.'s free cash flow?
Ainos, Inc.'s free-cash-flow margin is -33046.9% of revenue over the trailing twelve months.
Who are Ainos, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Geode Capital Management, LLC, HRT Financial LP and Keystone Financial Group. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Ainos, Inc.'s market cap?
On November 2, 2026, Ainos, Inc.'s market capitalisation was about $3.6M and net debt of -$1.4M. Market figures come from third-party market data and may be delayed.
Who are Ainos, Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Ainos, Inc. are Cuprina Holdings (cayman) LTD, Heartsciences Inc., Phaos Technology Holdings (cayman) Ltd, Pavmed Inc. and Nexalin Technology, Inc. The side-by-side comparison below sets their revenue, margins and growth against Ainos, Inc.'s.
Are insiders buying or selling Ainos, Inc. stock?
Over the last 12 months, Ainos, Inc.'s directors and officers reported 9 open-market purchases and 9 sales on Form 4. The insider trading page charts every trade.
When is Ainos, Inc.'s next earnings date?
Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Ainos, Inc. announces its own schedule.